Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

  • Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $0.98 per share a year ago.